期刊文献+

微波诱导燃烧法合成类花状ZnO纳米材料及其晶体结构、荧光性质研究(英文) 被引量:2

Microstructures and Photoluminescence Property of Flower-Like ZnO Nanopowders Synthesized by Microwave-Induced Combustion Technique
下载PDF
导出
摘要 以硝酸锌[Zn(NO3)2·6H2O]和尿素[CO(NH2)2]作前驱体,通过微波诱导燃烧技术可控合成具有不同形貌的ZnO纳米晶体,并用热重分析和差热分析进行了研究。对各种生长条件:微波功率.辐射时间和尿素/Zn^2+物质的量的比对ZnO纳米晶体形貌的影响作了分析。结果表明:尿素/Zn^2+物质的量的比对ZnO纳米材料的形貌具有显著影响。X衍射图表明合成的ZnO纳米结构呈六角形。傅里叶变换红外光谱图中400-500cm^-1,处明显的峰为Zn-O的振动峰。ZnO纳米结构的发光光谱在366nm的带边发射,因缺陷又由许多可见光发射峰组成。用扫描电子显微镜、透射电子显微镜、选区电子衍射研究了花状ZnO纳米结构的增长机理。本方法仅需几分钟就获得的了ZnO纳米结构。 ZnO crystals with different morphologies were controllably synthesized by the microwave-induced combustion technique. A solution of zinc nitrate [Zn(NO3)2-6H20] and urea [CO(NH2)2] was used as the precursor. The precursor of ZnO nanocrystal powders was studied by TG-DTA analysis. The effect of growth conditions, such as microwave power, radiation time, and urea/Zn2~ molar ratio, on the morphology of the ZnO nanocrystals was investigated. The results show that the molar ratio of urea/Zn2+ is the key factor affecting the morphology of the ZnO nanostructures. X-ray diffraction study indicates that the synthesized ZnO nanostructure is hexagonal. A sharp Zn-O vibration peak at 400-500 cm^-1 confirms the presence of ZnO. The photoluminescence spectrum of ZnO nanostructure consists of a band-edge emission at 366 nm and visible light emission peaks due to defects. Based on the morphological information provided by scanning electron microscopy, transmission electron microscopy, and selected area electron diffraction, a growth mechanism for the formation of flower-like ZnO nanostructures is suggested. It only takes a few minutes to obtain ZnO nanostructures by the present approach.
出处 《无机化学学报》 SCIE CAS CSCD 北大核心 2013年第1期190-198,共9页 Chinese Journal of Inorganic Chemistry
基金 中央高校基础研究基金(No.CDJXS10221136) 科技部国际技术计划合作项目(1010104520100174)资助项目
关键词 ZNO 微波燃烧 纳米结构 荧光 ZnO microwave combustion nanostructure photoluminescence
  • 相关文献

同被引文献41

  • 1王锡森,黄雪峰,熊仁根.{[Cd(sulfadiazine)_2]_n[C d(sulfadiazine)_2·H_2O]_n}[J].无机化学学报,2005,21(8):1279-1280. 被引量:5
  • 2Sun D F, Cao R, Sun Y Q, et al. Inorg. Chem., 2003,42: 7512-7518.
  • 3Li X, Wei D Y, Huang S J, et al. J. Solid State Chem., 2009, 182:95-101.
  • 4Kremer E, Facchin G, Estévez E, et al. J. Inorg. Biochem., 2006,100:1167-1175.
  • 5Supuran C T, Casini A, Scozzafava A, et al. Curr. Cancer Drug Targets, 2002,2:55-75.
  • 6Owa T, Nagasu T. Exp. Opin. Ther. Patents, 2000,10:1725-1740.
  • 7Supuran C T, Scozzafava A. Exp. Opin. Ther. Patents, 2000, 10:575-600.
  • 8Supuran C T, Scozzafava A. Curr. Med. Chem. Immunol. Endocrinol. Metab. Agents, 2001,1:61-97.
  • 9Lobb K L, Hipskind P A, Aikins J A, et al. J. Med. Chem., 2004,47:5367-5380.
  • 10Medina J C, Roche D, Shan B, et al. Bioorg. Med. Chem. Lett., 1999,9:1843-1846.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部